Atlas Trials

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00754923 · TERMINATED

Trial details

NCT number
NCT00754923
Sponsor
Ohio State University Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2008-10-01
Primary completion
2012-04-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.